ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,125, issued on April 22, was assigned to Novartis AG (Basel, Switzerland).
"Rapamycin derivatives" was invented by Simone Bonazzi (Cambridge, Mass.), Michael Connolly (Salem, Mass.), David Jonathan Glass (Cortland Manor, N.Y.), Manuel Mihalic (Grenzach-Wyhle, Germany), Andrew W. Patterson (Somerville, Mass.), Silvio Roggo (Muttenz, Switzerland), Tea Shavlakadze (Hawthorne, N.Y.) and Patrik Zueger (Basel, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides 32-deoxo-rapamycin derivatives of Formula (I), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions and pharmaceutical combinations comprising a ...